These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2165264)

  • 1. Validity of imipramine platelet binding sites as a biological marker of endogenous depression. A World Health Organization Collaborative Study.
    Pharmacopsychiatry; 1990 May; 23(3):113-7. PubMed ID: 2165264
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity.
    Tanimoto K; Maeda K; Terada T
    Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789
    [No Abstract]   [Full Text] [Related]  

  • 3. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet tritiated imipramine binding in patients suffering from mania.
    Ellis PM; Mellsop GW; Beeston R; Cooke RR
    J Affect Disord; 1991 Jul; 22(3):105-10. PubMed ID: 1655851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tritiated imipramine binding distinguishes among subtypes of depression.
    Lewis DA; McChesney C
    Arch Gen Psychiatry; 1985 May; 42(5):485-8. PubMed ID: 2985015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study.
    Bech P; Eplov L; Gastpar M; Gentsch C; Mendlewicz J; Plenge P; Rielaert C; Mellerup ET
    Pharmacopsychiatry; 1988 May; 21(3):147-50. PubMed ID: 2841696
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis.
    Wood PL; Suranyi-Cadotte B; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Jun; 18(6):715-9. PubMed ID: 6307404
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet [3H]imipramine binding in depressed patients and its circadian variations in healthy controls.
    Nankai M; Yoshimoto S; Narita K; Takahashi R
    J Affect Disord; 1986; 11(3):207-12. PubMed ID: 3031144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet [3H]-imipramine binding according to DSM-III subtypes of depression.
    Jeanningros R; Gronier B; Azorin JM; Tissot R
    Neuropsychobiology; 1989; 22(1):33-40. PubMed ID: 2561683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine binding in depressed patients with psychogenic pain.
    Mellerup ET; Dam H; Kim MY; Loldrup D; Plenge P; Rosenberg R; Schepelern S
    Psychiatry Res; 1990 Apr; 32(1):29-34. PubMed ID: 2161548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment.
    Hrdina PD; Lapierre YD; Horn ER; Bakish D
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):619-23. PubMed ID: 3003804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet [3H]imipramine binding in psychiatric disorders.
    Kanof PD; Coccaro EF; Johns CA; Siever LJ; Davis KL
    Biol Psychiatry; 1987 Mar; 22(3):278-86. PubMed ID: 3028513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression.
    Langer SZ; Sechter D; Loo H; Raisman R; Zarifian E
    Arch Gen Psychiatry; 1986 Oct; 43(10):949-52. PubMed ID: 3019267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tritiated imipramine binding to platelets in manic subjects.
    Lewis DA; McChesney C
    J Affect Disord; 1985 Nov; 9(3):207-11. PubMed ID: 3001164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects.
    Baron M; Barkai A; Kowalik S; Fieve RR; Quitkin F; Gruen R
    Neuropsychobiology; 1988; 19(1):9-11. PubMed ID: 2847077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet tritiated imipramine binding in psychiatric patients: relationship to symptoms and severity of depression.
    Ellis PM; McIntosh CJ; Beeston R; Salmond CE; Cooke RR; Mellsop G
    Acta Psychiatr Scand; 1990 Oct; 82(4):275-82. PubMed ID: 2175538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3H-imipramine binding sites in platelets from psychiatric patients.
    Mellerup ET; Plenge P; Rosenberg R
    Psychiatry Res; 1982 Oct; 7(2):221-7. PubMed ID: 6959172
    [No Abstract]   [Full Text] [Related]  

  • 20. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects.
    Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J
    Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.